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Background: High fat diets are known to increase body weight and fat mass, induce 
alterations in carbohydrate and lipid metabolism, leading to insulin resistance and diabetes 
mellitus. The aim of this study was to evaluate the effects of fermented soya bean supplements 
on lipid profile and oxidative stress biomarkers in high fat diet-induced type 2 diabetes 
mellitus in rabbits. Methods: Twenty rabbits weighing between 1kg – 2kg were used for the 
study. Type 2 diabetes mellitus was induced by feeding the animals with high fat diet (2% 
cholesterol, 20% groundnut meal, 10% groundnut oil) for eight weeks. Rabbits having fasting 
blood glucose levels of 7.2 mmol/L (130mg/dL) and above after the induction period were 
selected for the study. The animals were grouped into four groups of five rabbits each: Group 1 
(diabetic control), received distilled water ad libitum for six weeks; groups 2, 3 and 4 (diabetic 
rabbits) were fed with 12.5%, 25% and 50% fermented soya bean supplements respectively for 
six weeks. Thereafter, the rabbits were sacrificed  and blood samples obtained for analyses. 
Data were analysed using analysis of variance (ANOVA). Results: There was a significant 
decrease (p ≤ 0.05) in triglyceride and LDL concentrations in the group fed 50% fermented 
soya bean supplements and a significant increase in HDL levels (p ≤ 0.05) in all the fermented 
soya bean supplemented groups when compared with the diabetic control group. The result 
also showed a significant decrease (p ≤ 0.05) in malondialdehyde concentration in all the 
treated groups when compared with the control group. Superoxide dismutase was significantly 
decreased in the group fed 12.5% and 25% fermented soya bean supplements while catalase 
was significantly decreased in the group fed 12.5% fermented soya bean supplement when 
compared with the control group. Conclusion: Fermented soya bean supplements decreased 
lipid profile and improved antioxidant activities in diabetic rabbits and may prove beneficial in 
the management of hyperlipidaemia and oxidative stress in diabetic patients. 
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INTRODUCTION   
 Diabetes mellitus is a group of metabolic diseases 
characterized by hyperglycaemia resulting from defects 
in insulin secretion, insulin action, or both. This is 
associated with long-term damage, dysfunction, and 
failure of various organs, especially the eyes, kidneys, 
nerves, heart, and blood vessels. (ADA, 2006). The 
prevalence of diabetes mellitus has been steadily 
increasing for the past 3 decades and is growing most 
rapidly in low- and middle-income countries. 
 
 
Associated risk factors such as being overweight or 
obese are also increasing (WHO, 2016).  
Diabetes-related changes in serum lipid levels are 
among the key factors that increase the risk of 
cardiovascular related diseases (CVDs) and the high 
mortality rate associated with CVDs in patients with 
diabetes mellitus (Chen and Tseng, 2013; Firdous, 
2014). The lipid changes associated with diabetes 
mellitus is characterized by high plasma triglyceride 
(TG) concentration, low HDL cholesterol concentration 
and increased concentration of LDL-cholesterol 
particles, which has been attributed to increased free 
fatty acid flux (lipogenesis) that is secondary to insulin 
deficiency and insulin resistance (Chen and Tseng, 
2013; Firdous, 2014).  
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Hyperglycaemia in diabetes mellitus is one of the most 
important factors responsible for the development of 
oxidative stress, which underlies the major 
complications in diabetes mellitus patients (Vicentini et 
al., 2011; Aly and Mantawy, 2012). In the 
hyperglycaemic state, sugars react with lipids and 
proteins which results in the generation of reactive 
oxygen species (ROS) (Palmeira et al., 2001). The ROS 
enhance lipid peroxidation (Griesmacher et al., 1995) 
and causes damage to cells, tissues and biomolecules, 
thus contributing to diabetic complications (Mahmoud, 
2015). Advanced glycation end products (AGEs) are a 
heterogeneous group of molecules formed from non-
enzymatic reaction of reducing sugars 
(monosaccharides) with amino group of proteins, 
lipids, and nucleic acids. The AGEs interact with their 
cellular receptor “receptor for AGEs” (RAGE) and 
activates nuclear factor kappa-B (NF-κβ), generating 
ROS. NF-κβ increases the gene expression of 
cytokines, known to activate NADPH-oxidase, which 
generates ROS.  These cytokines include interleukins 
(IL-1, IL-6, IL-8) and tumor necrosis factor-α). NF-κβ 
also increase the gene expression of adhesion 
molecules, including vascular cell adhesion molecules-
1 (VCAM-1) and intercellular adhesion molecule-1 
(ICAM-1). Glycation and oxidative stress are closely 
linked and are often referred to as "glycoxidation" 
processes. (Bucala and Cerami, 1992; Yan et al., 1994; 
Kailash and Indu 2014).  
Soya beans belongs to the legume family and 
represents an excellent source of high quality protein, 
great amount of fibers, phytosterols including 
isoflavones, with a low content in saturated fat. Its 
isoflavone content makes it singular among other 
legumes (Hamada et al., 2002; Ren et al., 2006; Asif 
and Acharya, 2013). Soya bean have received increased 
attention as a functional food due to their beneficial 
physiological effects in controlling and preventing a 
wide variety of chronic and degenerative diseases (Sada 
et al., 2013; Ahmad et al., 2014). Hence, this research 
study was aimed at evaluating the effects of fermented 
soya beans supplements on lipid profile and oxidative 
stress biomarkers in high fat diet-induced diabetes in 
rabbits. 
 
MATERIALS AND METHODS:  
All chemicals used were of analytical grade: 
(Cholesterol: Kem Light Laboratories Pvt Ltd., 
Mumbai, India), digital glucometer and strips 
(Accucheck advantage, Boche Diagnostic, Company). 
 
Experimental Animals Twenty (20) rabbits of both 
sexes weighing between 1kg – 2kg were used for the 
study. The rabbits were handled in accordance with the 
principles guiding the use and handling of experimental 
animals, ABU, Zaria. Ethical approval was obtained, 
with Approval No: ABUCAUC/2017/035. The animals 
were fasted from feeds overnight for 12 hours prior to 
commencement of the experiment but allowed water ad 
libitum.  
 
Experimental Induction and Determination of Diabetes 
Mellitus  
Diabetes was induced by feeding the animals with a 
high fat diet (2% cholesterol, 20% groundnut meal 10% 
groundnut oil) for eight weeks. After eight weeks of 
feeding with the high fat diet, blood samples were 
collected from the rabbits and tested for 
hyperglycaemia using the glucose oxidase method 
(Beach and Turner, 1958), and by means of   a digital 
glucometer. Rabbits having fasting blood glucose levels 
of 7.2 mmol/L and above were selected for the study. 
  
Experimental design  
The animals were grouped into four groups of five 
rabbits each as follows: Group 1 (diabetic control), 
received distilled water orally for six weeks; Group 2 
(diabetic rabbits) were fed with 12.5% fermented soya 
beans supplement for six weeks; Group 3 (diabetic 
rabbits) were fed with 25% fermented soya beans 
supplement for six weeks; Group 4 (diabetic rabbits) 
were fed with 50% fermented soya beans supplement 
for six weeks.  
 
Collection and Preparation of Fermented Soya Bean 
Supplements 
The soya bean (variety, TGX-1448-2E) was purchased 
from Institute for Agricultural Research (IAR), 
Ahmadu Bello University, Zaria. The seeds were 
washed and soaked in a plastic container for forty-eight 
hours, with the water unchanged (fixed fermentation) 
(Uyoh et al., 2009). After fermentation, the seeds were 
drained, air dried, ground into fine granules and 
constituted into the 12.5%, 25% and 50% supplements 
with the normal animal feed (Grower’s mash from 
Vital Feeds Company Plc, Jos).  
 
Blood Sample Collection and Serum Preparation  
At the end of the six weeks treatment period, the rabbits 
were sacrificed by cervical dislocation and blood 
samples were collected from the animals through 
cardiac puncture for the determination of lipid profile. 
The blood was allowed to clot and the serum separated 
by centrifugation. 
 
Biochemical Estimations  
The sera were then used for the determination of total 
cholesterol by the method of Stein (1987), triglycerides  
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Table 1: Effect of fermented soya bean supplements on lipid profile in high fat diet– induced type 2 diabetes 
mellitus in rabbits 
 
Values are expressed as mean ± SEM; n = 5.  a: Value considered statistically significant when compared with control group (P 
≤ 0.05). SEM = Standard error of mean; HDL – High density lipoprotein, LDL - Low density lipoprotein, SY – Fermented 
soya bean supplement; n = Number of animals 
 
Table 2: Effect of fermented soya bean supplements on malondialdehyde and antioxidant biomarkers in 
high fat diet– induced type 2 diabetes mellitus in rabbits 
 
Values are expressed as mean ± SEM; n = 5. a: Value considered statistically significant when compared with control group (P 
≤ 0.05); SEM = Standard error of mean; MDA – Malondialdehyde; SOD – Superoxide dismutase; CAT – Catalase; GPx – 
Glutathione peroxidase; SY – Fermented soya bean supplement; n = Number of animals. 
 
 
by the method of Tietz (1990) and high-density 
lipoprotein (HDL) by the method of Wacnic and Albers 
(1978). These were determined spectrophotometrically, 
using enzymatic colometric assay kits. The serum level 
of low density lipoprotein (LDL) was measured 
according to the protocol of Friedewald et al., (1972) 
using the following equation: LDL-C = TC - (TG/5 + 
HDL-C). Glutathione peroxidase (GPx) was estimated 
by the method of Avissar et al., (1994), superoxide 
dismutase (SOD) by the method of Martin et al., 
(1987), catalase (CAT) by the method of Beers and 
Sizer (1952) and malondialdehyde (MDA) according to 
the method described by Janero (1990). 
 
Statistical Analysis  
Data obtained from the study were expressed as mean ± 
SEM. Statistical comparisons were performed by one-
way analysis of variance (ANOVA). The results were 
considered statistically significant if P ≤ 0.05. 
 
DISCUSSION 
Dyslipidaemia is common in both insulin deficiency 
and insulin resistance, which affects enzymes and 
pathways of lipid metabolism. It is a major risk factor 
for cardiovascular diseases which is currently a leading 
cause of morbidity and mortality worldwide (Yadav et 
al., 2007). The result of the present study showed a 
significant increase in total cholesterol concentration in 
the group fed 12.5% fermented soya bean supplement 
when compared with the diabetic untreated control 
group. Though a decrease was observed in the groups 
fed 25% and 50% fermented soya bean supplements, 
the decrease was not statistically significant. However, 
long-term supplementation with 25% and 50% may 
ensure that the decrease in total cholesterol is 
biologically relevant and hence clinically useful to the 
diabetic patient. 
The result also showed a significant decrease in LDL 
concentration in the group fed 50% fermented soya 
bean supplement when compared with the untreated 
diabetic control group. Many nutritional factors such as 
isoflavones, saponins and tannins have been reported to 
contribute to the ability of plant derived medicines to 
improve dyslipidaemia (Nimenibo-Uadia, 2003; Rotimi 
et al., 2011). Soya bean proteins especially glycinin and 
β-conglycinin may be responsible for the decrease in 
cholesterol concentration by causing an increase in bile 
acid production and excretion via faeces (Kim et al., 
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1980; Beynen, 1990; Ferreira et al., 2010), leading to a 
shift in hepatic cholesterol system to provide more 
cholesterol for the bile acid deficit; and at the same 
time, causing increased LDL receptor activity; with the 
whole mechanism leading to a reduction in total blood 
cholesterol concentration (Tanaka et al., 1984). 
Peptides from protein hydrolysates (due to their 
hydrophobicity) have high binding ability with bile acid 
and greatly reduce the cholesterol concentration by 
restricting the reabsorption of the bile acid in the ileum 
(Iwami et al., 1986) and the Jejunum (Nagaoka et al., 
1997); inhibiting the micelles solubility of cholesterol 
and ultimately causing the reduction in the cholesterol 
absorption. This is achieved by the direct interaction of 
the cholesterol mixed micelles and soya bean protein 
peptic hydrolysates with the bound phospholipids in the 
jejunal epithelia (Nagaoka et al., 1997). Soya proteins 
also have a direct effect on the hepatic metabolism of 
cholesterol (Nagaoka et al., 1997). Besides soya 
proteins, soya isoflavones were also reported to 
decrease the plasma cholesterol by arresting the hepatic 
assembly as well as by inhibiting the secretion of apo 
B- containing lipoproteins (Borradaile et al., 2002). 
The increase in total cholesterol observed in the group 
fed 12.5% fermented soya bean supplement could be 
due to the lower percentage supplementation and may 
probably suggest that higher amount of the soya bean 
supplementation provides a better cholesterol lowering 
effect as seen by the dose dependent decrease in the 
25% and 50% supplements.  
Low serum triacylglycerides (TGs) has been reported to 
reduce the risk of CVDs, while high serum level of TGs 
is classified as an independent predictor of CVDs 
(Chen and Tseng, 2013). The result of the present study 
showed a significant decrease in the triacylglyceride 
concentration in the groups fed 12.5% and 50% 
fermented soya bean supplements. The decrease in the 
triacylglyceride concentration was more with the 50% 
supplement, indicating a better therapeutic benefit with 
the consumption of higher percentage of the fermented 
soya beans. About 30% of blood cholesterol is carried 
in the form of HDL-C. HDL-C function to remove 
cholesterol atheroma within arteries and transport it 
back to the liver for its excretion or reutilization, thus 
high levels of HDL-C protect against cardiovascular 
diseases (Kwiterovich, 2000; James et al., 2010). The 
result of this study showed a statistically significant 
increase in HDL-C level in all the treated groups 
compared with the untreated diabetic control group, 
which confirms the protective effect of soya beans 
against hyperlipidaemia. These findings are in 
agreement with the result of Sartang et al., (2015) who 
reported that fermented soy milk decreased total 
cholesterol and triacylglyceride concentrations, and 
increased HDL concentration in diabetic rats. 
The present study showed a significant decrease in 
MDA levels in the fermented soya bean supplemented 
groups when compared with the untreated diabetic 
control group, indicating reduced lipid peroxidation in 
the treated groups. The antioxidant enzymes (SOD and 
CAT) were significantly decreased with the 12.5% and 
25% supplementation when compared with the 
untreated diabetic control group. Their levels were 
however, increased in the 50% supplemented group, 
though not statistically significant. GPx showed no 
significant difference between all the groups, although 
slight decreases were observed in all the treated groups 
when compared with the untreated diabetic control 
group. 
The antioxidant enzymes (SOD, CAT and GPx) form 
the first line of defence against ROS in an organism. 
They play an important role in scavenging the toxic 
intermediates of incomplete oxidation. The SOD 
catalyses the dismutation of superoxide anion into 
hydrogen peroxide (H2O2), which is then degraded to 
water (H2O) by CAT or GPx. The decrease in the 
antioxidant enzyme levels seen in this study might 
therefore be due to the enzymes utilization in 
alleviating the oxidative stress, seen as decrease in the 
level of MDA. The antioxidant activities of soymilk 
and fermented soymilk have been observed in other 
studies (Seo et al., 2009 and Sartang et al., 2015), 
which were attributed to soya isoflavones, soya protein, 
and saponins (Esaki et al., 1998). The increase in the 
antioxidant enzymes SOD and CAT in the groups fed 
50% fermented soya bean supplements may be due to 
upregulation of the endogenous antioxidant enzymes 
activities by fermented soya bean supplements. This 
imply that higher percentage of fermented soya bean 
supplementation is able to stimulate increased SOD and 
CAT levels, and hence scavenging capacity for ROS; 
thus providing higher protection against oxidative 
damage induced by diabetes.  
 
CONCLUSION 
The results of this study show that fermented soya bean 
supplementation decreases serum cholesterol, serum 
triglyceride and serum LDL concentrations, and 
increase serum HDL concentration, when compared 
with the diabetic control.  
This shows the efficacy of fermented soya bean 
supplement as an anti-lipidaemic and antioxidant food 
that abates diabetes related cardiovascular 
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